Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

1Solutions

1Solutions is a performance-driven digital marketing and technology solutions company helping businesses grow through SEO, performance marketing, and scalable development. We specialize in SEO, AI-powered marketing, paid advertising, website & eCommerce development, CRM/ERP systems, app development, and ongoing support & maintenance- all focused on measurable growth and ROI.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

1Solutions
{28.635345001438644,77.28345895470046}
+91 9654327900
Contact 1Solutions
Website

 Latest Content from PMHub 

Announcing a change of leadership at the US Philadelphia office

White Papers and Resources | December 19, 2019 | Inizio

Research Partnership’s Philadelphia office is announcing a change of leadership from the start of 2020. President Harriet Kozak will be stepping down in order to take retirement at the end...

Are supermarkets responsible for public health?

White Papers and Resources | December 18, 2019 | Page & Page Health

If supermarkets don't shoulder some of the responsiblity for the public health crisis, it'll only get worse. But would they risk the financial impact?

Clinical trials, Actually.

Videos and Podcasts | December 18, 2019 | Cuttsy + Cuttsy

This Christmas, we’re thinking of the thousands of clinical trial volunteers across the UK, both patients and healthy participants. We have a lot to thank them for...

Silos – a reflection on the second birthday of Porterhouse Insights

White Papers and Resources | December 16, 2019 | Porterhouse Medical Group

After another exciting year, Fabrice Allum, Managing Director at Porterhouse Insights, reflects on the benefits of cross-functional working for our pharmaceutical clients

Five key trends in precision and personalised healthcare

White Papers and Resources | December 6, 2019 | Blue Latitude Health

Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...

OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications

White Papers and Resources | December 6, 2019 | OPEN Health

Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications

Middlesex House hosts its first Lucid Spirit pub quiz

Press Releases | December 6, 2019 | Lucid Group Communications Limited

Dec 6, 2019Middlesex House hosted its first Lucid Spirit fundraising activity for its charity partner the Wycombe Homeless Connection. The turnout was excellent, and everyone’s synapses were on fire. However,...

Language barriers: Obesity has become a loaded word

White Papers and Resources | December 5, 2019 | Say Communications

We have a worldwide ‘obesity crisis’. Everyone knows this; obesity is in the news almost every week for one reason or another, but what we seem less sure of is...

Spotlight interview: 15 minutes on digital in medical communications

White Papers and Resources | December 5, 2019 | OPEN Health

Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

Generating data on long-term outcomes with gene and other advanced therapies

White Papers and Resources | December 5, 2019 | OPEN Health

Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.